Exploring the Treatment Landscape for Triple-Negative Breast Cancer

Host: Pavani Chalasani, MD, MPH Guest: Aditya Bardia, MD, MPH Triple-negative breast cancer can be a challenging battle for patients, especially when it comes to treatment. And that's why the ASCENT trial dove into the treatment landscape for these patients. Lead investigator of this trial, Dr. Aditya Bardia, sits down with Dr. Pavani Chalasani for an inside look at this trial and what it means for patients with triple-negative breast cancer.